修改后的Saengmaeksan,一个含有六种草药的草药配方,通过RhoA/Rho激酶介导的血管松来改善高血压
Young Mi Seok1, Hye-Lin Kim2,3, Hyo In Kim4
1Department of Industry Promotion, National Institute for Korean Medicine Development, Gyeongsan, Korea.
Integrative medicine research
|September 2, 2025
概括
修改后的Saengmaeksan草药配方 (mSMS) 通过抑制RhoA/ Rho- kinase通路并减少血管损伤,有效降低高血压患者的血压. 这种天然化合物可用于治疗高血压.
科学领域:
- 药理学
- 植物医学
- 心血管研究
背景情况:
- 这是韩国传统的草药配方.
- 使用特定的草本成分开发了一个修改后的配方 (mSMS).
- 这项研究旨在评估mSMS的抗高血压作用.
研究的目的:
- 研究mSMS的体内和体外抗高血压作用.
- 阐明mSMS作用的基础分子机制.
- 评估mSMS对血管,氧化应激和的保护作用.
主要方法:
- 在l-NAME诱导的高血压小鼠和自发高血压大鼠 (SHR) 中评估了抗高血压疗效.
- 通过器官浴室研究和大动脉组织学评估血管效应.
- 使用各种测定和染色技术评估了氧化应激,保护和分子通路 (RhoA/Rho kinase).
主要成果:
- 在这两种高血压模型中,mSMS显著降低了静缩和腹缩血压.
- mSMS的乙醇提取物显示出更高的疗效.
- mSMS抑制了RhoA/ Rho- kinase通路,改善了血管放松,减少了大动脉壁的加厚,氧化应激和损伤,降低了AT1R的表达.
结论:
- 通过RhoA/ Rho- kinase通路的抑制,mSMS表现出强大的抗高血压作用.
- 提供血管改造,氧化应激和保护.
- mSMS具有作为一种新型,多向的高血压治疗药物的潜力,副作用较少.
更多相关视频
相关概念视频
Antihypertensive Drugs: Vasodilators
642
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
642
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
871
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
871
Hypertension II: Pathophysiology
77
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
77
Antihypertensive Drugs: Direct Renin Inhibitors
817
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
817
Antihypertensive Drugs: Angiotensin II Receptor Blockers
911
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
911


